Cover Image
QR Code

Inhibition of Interleukin-12 and/or -23 for the Treatment of Inflammatory Bowel Disease.

Published in:Gastroenterology & Hepatology Vol. 12; no. 12; pp. 784 - 787
Main Author: Sands, Bruce E.
Format: questions and answers Journal Article
Published: Gastro-Hep Communications, Inc Dec2016
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120180563&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 120180563
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15547914
        6N5B
      jtl: Gastroenterology & Hepatology
      issn: 15547914
      maglogo: N
    pubinfo:
      dt: Dec2016
      vid: 12
      iid: 12
      pid: 72163
      pub: Gastro-Hep Communications, Inc
      place: New York, New York
    artinfo:
      ui:
        120180563
        120180563
        120180563
        120180563
      ppf: 784
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Inhibition of Interleukin-12 and/or -23 for the Treatment of Inflammatory Bowel Disease.
      aug:
        au: Sands, Bruce E.
        affil: Dr Burrill B. Crohn Professor of Medicine, The Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York
      sug:
        subj:
          Inflammatory Bowel Diseases
          Crohn Disease
          Interleukins
          Crohn Disease Therapy
          Silicon Dioxide
      pubtype: Academic Journal
      doctype:
        questions and answers
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N